IL6 and cancer: IL-6 and oncostatin M have been found to directly stimulate enhanced invasion of cancer cells, stimulate the promotion of cell cycle, enhance resistance to chemotherapy, and cause epithelial-to-mesenchymal transition (EMT) [37].